Back to the future: Funding, integrating, and improving mental health services

Psychiatric Services

Volumn 55, Issue 10, 2004, Pages 1141-1142

  Rosenheck, Robert A ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; OLANZAPINE; RISPERIDONE;

CLINICAL PRACTICE; COST CONTROL; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOMELESSNESS; HOUSING; HUMAN; LOWEST INCOME GROUP; MEDICAID; MEDICAL LITERATURE; MEDICAL SOCIETY; MENTAL DISEASE; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; NOTE; OUTCOMES RESEARCH; POLICY; PSYCHOSOCIAL CARE; PUBLIC HEALTH; PUBLIC MENTAL HEALTH; PUBLICATION; SALARY; SCHIZOPHRENIA; SIDE EFFECT; UNITED STATES;

DELIVERY OF HEALTH CARE, INTEGRATED; FINANCING, ORGANIZED; MENTAL DISORDERS; MENTAL HEALTH SERVICES; QUALITY OF HEALTH CARE; UNITED STATES;

EID: 4744349919     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ps.55.10.1141     Document Type: Note

References (12)

1. Von Hoffman A: House by House, Block by Block: The Rebirth of America's Urban Neighborhoods. New York, Oxford University Press, 2003
2. Appelbaum PS: Response to the presidential address: the systematic defunding of psychiatric care: a crisis at our doorstep. American Journal of Psychiatry 159:1638-1640, 2002
3. Lehman A, Postrado L, Roth D, et al: Continuity of care and client outcomes in the Robert Wood Johnson Foundation Program on chronic mental illness. Millbank Quarterly 72:105-122, 1995
4. Bickman L, Guthrie PR, Foster EM, et al: Evaluating Managed Mental Health Services: The Fort Bragg Experiment. New York, Plenum, 1995
5. Goldman HH, Morrissey J, Rosenheck RA, et al, and the ACCESS National Evaluation Team: Lessons from the evaluation of the ACCESS program. Psychiatric Services 53:967-970, 2002
6. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry 45:789-796, 1988
7. Rosenheck RA, Perlick D, Bingham S, et al, for the Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine: Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia. JAMA 290:2693-2702, 2003
8. Sernyak MJ, Leslie D, Alarcon R, et al: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry 159:561-566, 2002.
9. Katon W, Von Korff M, Lin E, et al: Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 273:1026-1031, 1995
10. Rosenheck RA, Kasprow W, Frisman LK, et al: Cost-effectiveness of supported housing for homeless persons with mental illness. Archives of General Psychiatry 60:940-951, 2003
11. Drake RE, Goldman HH, Leff HS, et al: Implementing evidence-based practices in routine mental health service settings. Psychiatric Services 52:179-182, 2001
12. Institute of Medicine Committee on Quality of Health Care in America: Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academy Press, 2001